Abstract
BAK/BAX-mediated mitochondrial outer-membrane permeabilization (MOMP) drives cell death during development and tissue homeostasis from zebrafish to humans. In most cancers, this pathway is inhibited by BCL-2 family antiapoptotic members, which bind and block the action of proapoptotic BCL proteins. We report the 1.5 A crystal structure of calpain-proteolysed BAK, cBAK, to reveal a zinc binding site that regulates its activity via homodimerization. cBAK contains an occluded BH3 peptide binding pocket that binds a BID BH3 peptide only weakly . Nonetheless, cBAK requires activation by truncated BID to induce cytochrome c release in mitochondria isolated from bak/bax double-knockout mouse embryonic fibroblasts. The BAK-mediated MOMP is inhibited by low micromolar zinc levels. This inhibition is alleviated by mutation of the zinc-coordination site in BAK. Our results link directly the antiapoptotic effects of zinc to BAK.
Publication types
-
Comparative Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Amino Acid Sequence
-
Animals
-
Apoptosis / drug effects
-
Binding Sites
-
Calpain / metabolism
-
Chlorides / pharmacology*
-
Crystallography, X-Ray
-
Humans
-
KB Cells
-
Magnetic Resonance Spectroscopy
-
Mice
-
Models, Molecular
-
Molecular Sequence Data
-
Peptide Fragments / metabolism
-
Protein Conformation
-
Protein Structure, Secondary
-
Proto-Oncogene Proteins / metabolism
-
Recombinant Proteins / antagonists & inhibitors
-
Recombinant Proteins / chemistry
-
Recombinant Proteins / genetics
-
Sensitivity and Specificity
-
Zinc Compounds / pharmacology*
-
bcl-2 Homologous Antagonist-Killer Protein / antagonists & inhibitors*
-
bcl-2 Homologous Antagonist-Killer Protein / chemistry*
-
bcl-2 Homologous Antagonist-Killer Protein / genetics
Substances
-
BAK1 protein, human
-
Bax protein (53-86)
-
Chlorides
-
Peptide Fragments
-
Proto-Oncogene Proteins
-
Recombinant Proteins
-
Zinc Compounds
-
bcl-2 Homologous Antagonist-Killer Protein
-
zinc chloride
-
Calpain